Some advocacy groups, such as No Free Lunch and AllTrials, have criticized the effect of drug marketing to physicians because they say it biases physicians to prescribe the marketed drugs even when others might be cheaper or better for the patient [REF].
There have been related accusations of disease mongering[REF](over-medicalising) to expand the market for medications.